|
1
|
Hegyi M, Semsei AF, Jakab Z, et al: Good
prognosis of localized osteosarcoma in young patients treated with
limb-salvage surgery and chemotherapy. Pediatr Blood Cancer.
57:415–422. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mialou V, Philip T, Kalifa C, et al:
Metastatic osteosarcoma at diagnosis: prognostic factors and
long-term outcome-the French pediatric experience. Cancer.
104:1100–1109. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Stokkel MP, Linthorst MF, Borm JJ,
Taminiau AH and Pauwels EK: A reassessment of bone scintigraphy and
commonly tested pretreatment biochemical parameters in newly
diagnosed osteosarcoma. J Cancer Res Clin Oncol. 128:393–399. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zhao H, Guo M, Zhao G, Ma Q, Ma B, Qiu X,
et al: miR-183 inhibits the metastasis of osteosarcoma via
downregulation of the expression of Ezrin in F5M2 cells. Int J Mol
Med. 30:1013–1020. 2012.PubMed/NCBI
|
|
5
|
Wu X, Zhong D, Gao Q, Zhai W, Ding Z and
Wu J: MicroRNA-34a inhibits human osteosarcoma proliferation by
downregulating ether a go-go 1 expression. Int J Med Sci.
10:676–682. 2013. View Article : Google Scholar
|
|
6
|
Dong Q, Meng P, Wang T, Qin W, Wang F,
Yuan J, et al: MicroRNA let-7a inhibits proliferation of human
prostate cancer cells in vitro and in vivo by targeting E2F2 and
CCND2. PLoS One. 5:e101472010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Johnson SM, Grosshans H, Shingara J, Byrom
M, Jarvis R, Cheng A, et al: RAS is regulated by the let-7 microRNA
family. Cell. 120:635–647. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Takamizawa J, Konishi H, Yanagisawa K,
Tomida S, Osada H, Endoh H, et al: Reduced expression of the let-7
microRNAs in human lung cancers in association with shortened
postoperative survival. Cancer Res. 64:3753–3756. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Nadiminty N, Tummala R, Lou W, Zhu Y, Shi
XB, Zou JX, et al: MicroRNA let-7c is downregulated in prostate
cancer and suppresses prostate cancer growth. PLoS One.
7:e328322012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
De Vito C, Riggi N, Suva ML, Janiszewska
M, Horlbeck J, Baumer K, et al: Let-7a is a direct EWS-FLI-1 target
implicated in Ewing's sarcoma development. PLoS One. 6:e235922011.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yang WH, Lan HY, Tai SK and Yang MH:
Repression of bone morphogenetic protein 4 by let-7i attenuates
mesenchymal migration of head and neck cancer cells. Biochem
Biophys Res Commun. 433:24–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kelly AD, Haibe-Kains B, Janeway KA, Hill
KE, Howe E, Goldsmith J, et al: MicroRNA paraffin-based studies in
osteosarcoma reveal reproducible independent prognostic profiles at
14q32. Genome Med. 5:22013. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhu XP, Liu ZL, Peng AF, Zhou YF, Long XH,
Luo QF, et al: Inhibition of Aurora-B suppresses osteosarcoma cell
migration and invasion. Exp Ther Med. 7:560–564. 2014.PubMed/NCBI
|
|
14
|
Liu P, Qi M, Ma C, Lao G and Liu Y: Let7a
inhibits the growth of endometrial carcinoma cells by targeting
Aurora-B. FEBS Lett. 587:2523–2529. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xie D, Shang C, Zhang H, Guo Y and Tong X:
Up-regulation of miR-9 target CBX7 to regulate invasion ability of
bladder transitional cell carcinoma. Med Sci Monit. 21:225–230.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yang N, Kaur S, Volinia S, Greshock J,
Lassus H, Hasegawa K, et al: MicroRNA microarray identifies Let-7i
as a novel biomarker and therapeutic target in human epithelial
ovarian cancer. Cancer Res. 68:10307–10314. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Balakathiresan N, Bhomia M, Chandran R,
Chavko M, McCarron RM and Maheshwari RK: MicroRNA let-7i is a
promising serum biomarker for blast-induced traumatic brain injury.
J Neurotrauma. 29:1379–1387. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Liu K, Qian T, Tang L, Wang J, Yang H and
Ren J: Decreased expression of microRNA let-7i and its association
with chemo-therapeutic response in human gastric cancer. World J
Surg Oncol. 10:2252012. View Article : Google Scholar
|
|
19
|
Lai NS, Yu HC, Chen HC, Yu CL, Huang HB
and Lu MC: Aberrant expression of microRNAs in T cells from
patients with ankylosing spondylitis contributes to the
immunopathogenesis. Clin Exp Immunol. 173:47–57. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang P, Ma Y, Wang F, Yang J, Liu Z, Peng
J, et al: Comprehensive gene and microRNA expression profiling
reveals the crucial role of hsa-let-7i and its target genes in
colorectal cancer metastasis. Mol Biol Rep. 39:1471–1478. 2012.
View Article : Google Scholar
|
|
21
|
Zhang L and Zhang S: ZM447439, the Aurora
kinase B inhibitor, suppresses the growth of cervical cancer SiHa
cells and enhances the chemosensitivity to cisplatin. J Obstet
Gynaecol Res. 37:591–600. 2011. View Article : Google Scholar
|
|
22
|
Takeshita M, Koga T, Takayama K, Ijichi K,
Yano T, Maehara Y, et al: Aurora-B overexpression is correlated
with aneuploidy and poor prognosis in non-small cell lung cancer.
Lung Cancer. 80:85–90. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Tuncel H, Shimamoto F, Kaneko Guangying Qi
H, Aoki E, Jikihara H, Nakai S, et al: Nuclear Aurora B and
cytoplasmic Survivin expression is involved in lymph node
metastasis of colorectal cancer. Oncol Lett. 3:1109–1114.
2012.PubMed/NCBI
|
|
24
|
Pohl A, Azuma M, Zhang W, Yang D, Ning Y,
Winder T, et al: Pharmacogenetic profiling of Aurora kinase B is
associated with overall survival in metastatic colorectal cancer.
Pharmacogenomics J. 11:93–99. 2011. View Article : Google Scholar
|
|
25
|
Qi G, Ogawa I, Kudo Y, Miyauchi M,
Siriwardena BS, Shimamoto F, et al: Aurora-B expression and its
correlation with cell proliferation and metastasis in oral cancer.
Virchows Arch. 450:297–302. 2007. View Article : Google Scholar : PubMed/NCBI
|
